Pembrolizumab in pre-treated advanced non-small cell lung cancer (NSCLC) patients (pts): Impact of blood-based biomarkers on survival outcomes
Ortega Franco, A., Tay, R., Raja, H., Ackermann, C.J., Carter, M., Lindsay, C., Hughes, S., Cove-Smith, L., Taylor, P., Summers, Y., Blackhall, F.H., Califano, R.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.229
Date:
September, 2020
File:
PDF, 69 KB
2020